Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Dec;85(12):1831–1837. doi: 10.1054/bjoc.2001.2187

Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements

C Mechler 1,1, A Bounacer 2,1,2, H Suarez 2, M Saint Frison 1, C Magois 3, G Aillet 3, A Gaulier 1
PMCID: PMC2364019  PMID: 11747322

Abstract

Familial papillary thyroid carcinoma (PTC) is a well recognized disease. However, genetic predisposition to familial PTC is rare and the molecular alterations at the origin of the pathology are unknown. The association between PTC and lymphocytic thyroiditis (LT) has been reported recently. We communicate here 6 cases of PTC associated with LT in 2 unrelated families. PTC was diagnosed on classical nuclear and architectural criteria. It was bilateral in 5 cases. Architecture was equally distributed between typical PTC and its follicular variant. LT was present in variable degrees, including in 4 cases, oncocytic metaplasia. Using the RT-PCR technique, we observed a RET/PTC rearrangement in the carcinomatous areas of patients of both families: PTC1 in family 1 and PTC3 in family 2 and a RET/PTC rearrangement in non-malignant thyroid tissue with LT in family 2. The RET/PTC band was weaker or absent in pure LT areas. Furthermore, using a polyclonal ret antibody, an apical or a diffuse cytoplasmic ret onc protein immunolabelling was observed in the three patients with RET/PTC1 rearrangement and in the three patients with RET/PTC3 rearrangement. In conclusion our data: (1) show the presence of a RET/PTC 1 or 3 rearrangement (depending on the family) together with a variable expression of ret protein in all the PTCs; (2) suggest that the molecular event at the origin of the PTCs seems to be particular to each one of the studied families; and (3) confirm that the ret proto-oncogene activating rearrangement(s) is an early event in the thyroid tumorigenic process and that it can be observed in association with LT. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: familial PTC, lymphocytic thyroiditis, ret oncogene activation

Full Text

The Full Text of this article is available as a PDF (112.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bongarzone I., Monzini N., Borrello M. G., Carcano C., Ferraresi G., Arighi E., Mondellini P., Della Porta G., Pierotti M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol. 1993 Jan;13(1):358–366. doi: 10.1128/mcb.13.1.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bongarzone I., Pierotti M. A., Monzini N., Mondellini P., Manenti G., Donghi R., Pilotti S., Grieco M., Santoro M., Fusco A. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene. 1989 Dec;4(12):1457–1462. [PubMed] [Google Scholar]
  3. Bounacer A., Wicker R., Caillou B., Cailleux A. F., Sarasin A., Schlumberger M., Suárez H. G. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 1997 Sep;15(11):1263–1273. doi: 10.1038/sj.onc.1200206. [DOI] [PubMed] [Google Scholar]
  4. Bunone G., Uggeri M., Mondellini P., Pierotti M. A., Bongarzone I. RET receptor expression in thyroid follicular epithelial cell-derived tumors. Cancer Res. 2000 Jun 1;60(11):2845–2849. [PubMed] [Google Scholar]
  5. Cetta F., Chiappetta G., Melillo R. M., Petracci M., Montalto G., Santoro M., Fusco A. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. J Clin Endocrinol Metab. 1998 Mar;83(3):1003–1006. doi: 10.1210/jcem.83.3.4614. [DOI] [PubMed] [Google Scholar]
  6. Cho J. Y., Sagartz J. E., Capen C. C., Mazzaferri E. L., Jhiang S. M. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene. 1999 Jun 17;18(24):3659–3665. doi: 10.1038/sj.onc.1202709. [DOI] [PubMed] [Google Scholar]
  7. Delvincourt C., Patey M., Flament J. B., Suarez H. G., Larbre H., Jardillier J. C., Delisle M. J. Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region. Clin Biochem. 1996 Jun;29(3):267–271. doi: 10.1016/0009-9120(96)00006-9. [DOI] [PubMed] [Google Scholar]
  8. Fischer D. K., Groves M. D., Thomas S. J., Jr, Johnson P. C., Jr Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest. 1989;7(4):323–325. doi: 10.3109/07357908909039857. [DOI] [PubMed] [Google Scholar]
  9. Fugazzola L., Pierotti M. A., Vigano E., Pacini F., Vorontsova T. V., Bongarzone I. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene. 1996 Sep 5;13(5):1093–1097. [PubMed] [Google Scholar]
  10. Gaulier A., Fourcade C., Szekeres G., Pulik M. Bone marrow one step fixation-decalcification in Lowy FMA solution: an immunohistological and in situ hybridization study. Pathol Res Pract. 1994 Dec;190(12):1149–1161. doi: 10.1016/s0344-0338(11)80441-3. [DOI] [PubMed] [Google Scholar]
  11. Gorson D. Familial papillary carcinoma of the thyroid. Thyroid. 1992 Summer;2(2):131–132. doi: 10.1089/thy.1992.2.131. [DOI] [PubMed] [Google Scholar]
  12. Grieco M., Santoro M., Berlingieri M. T., Melillo R. M., Donghi R., Bongarzone I., Pierotti M. A., Della Porta G., Fusco A., Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990 Feb 23;60(4):557–563. doi: 10.1016/0092-8674(90)90659-3. [DOI] [PubMed] [Google Scholar]
  13. Ishizaka Y., Kobayashi S., Ushijima T., Hirohashi S., Sugimura T., Nagao M. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 1991 Sep;6(9):1667–1672. [PubMed] [Google Scholar]
  14. Ishizaka Y., Shima H., Sugimura T., Nagao M. Detection of phosphorylated retTPC oncogene product in cytoplasm. Oncogene. 1992 Jul;7(7):1441–1444. [PubMed] [Google Scholar]
  15. Jhiang S. M., Sagartz J. E., Tong Q., Parker-Thornburg J., Capen C. C., Cho J. Y., Xing S., Ledent C. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology. 1996 Jan;137(1):375–378. doi: 10.1210/endo.137.1.8536638. [DOI] [PubMed] [Google Scholar]
  16. Jhiang S. M. The RET proto-oncogene in human cancers. Oncogene. 2000 Nov 20;19(49):5590–5597. doi: 10.1038/sj.onc.1203857. [DOI] [PubMed] [Google Scholar]
  17. Klugbauer S., Jauch A., Lengfelder E., Demidchik E., Rabes H. M. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8). Cancer Res. 2000 Dec 15;60(24):7028–7032. [PubMed] [Google Scholar]
  18. Klugbauer S., Rabes H. M. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene. 1999 Jul 29;18(30):4388–4393. doi: 10.1038/sj.onc.1202824. [DOI] [PubMed] [Google Scholar]
  19. Lote K., Andersen K., Nordal E., Brennhovd I. O. Familial occurrence of papillary thyroid carcinoma. Cancer. 1980 Sep 1;46(5):1291–1297. doi: 10.1002/1097-0142(19800901)46:5<1291::aid-cncr2820460534>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  20. Mayr B., Pötter E., Goretzki P., Rüschoff J., Dietmaier W., Hoang-Vu C., Dralle H., Brabant G. Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany. Langenbecks Arch Surg. 1999 Feb;384(1):54–59. doi: 10.1007/s004230050174. [DOI] [PubMed] [Google Scholar]
  21. McKee R. F., Krukowski Z. H., Matheson N. A. Thyroid neoplasia coexistent with chronic lymphocytic thyroiditis. Br J Surg. 1993 Oct;80(10):1303–1304. doi: 10.1002/bjs.1800801028. [DOI] [PubMed] [Google Scholar]
  22. Michelin S., Daya-Grosjean L., Sureau F., Saïd S., Sarasin A., Suárez H. G. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Oncogene. 1993 Jul;8(7):1983–1991. [PubMed] [Google Scholar]
  23. Nakayama S., Iida K., Tsuzuki T., Iwashita T., Murakami H., Asai N., Iwata Y., Ichihara M., Ito S., Kawai K. Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells. Br J Haematol. 1999 Apr;105(1):50–57. [PubMed] [Google Scholar]
  24. Okayasu I., Fujiwara M., Hara Y., Tanaka Y., Rose N. R. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer. 1995 Dec 1;76(11):2312–2318. doi: 10.1002/1097-0142(19951201)76:11<2312::aid-cncr2820761120>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  25. Reda G., Cesareo R., Lolli E., Gargiulo A. Cancro della tiroide e tiroidite di Hashimoto. Minerva Chir. 1997 Jan-Feb;52(1-2):139–141. [PubMed] [Google Scholar]
  26. Ron E., Kleinerman R. A., LiVolsi V. A., Fraumeni J. F., Jr Familial nonmedullary thyroid cancer. Oncology. 1991;48(4):309–311. doi: 10.1159/000226948. [DOI] [PubMed] [Google Scholar]
  27. Santoro M., Chiappetta G., Cerrato A., Salvatore D., Zhang L., Manzo G., Picone A., Portella G., Santelli G., Vecchio G. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene. 1996 Apr 18;12(8):1821–1826. [PubMed] [Google Scholar]
  28. Santoro M., Dathan N. A., Berlingieri M. T., Bongarzone I., Paulin C., Grieco M., Pierotti M. A., Vecchio G., Fusco A. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene. 1994 Feb;9(2):509–516. [PubMed] [Google Scholar]
  29. Sarasin A., Bounacer A., Lepage F., Schlumberger M., Suarez H. G. Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours. C R Acad Sci III. 1999 Feb-Mar;322(2-3):143–149. doi: 10.1016/s0764-4469(99)80037-7. [DOI] [PubMed] [Google Scholar]
  30. Sclafani A. P., Valdes M., Cho H. Hashimoto's thyroiditis and carcinoma of the thyroid: optimal management. Laryngoscope. 1993 Aug;103(8):845–849. doi: 10.1288/00005537-199308000-00003. [DOI] [PubMed] [Google Scholar]
  31. Soh E. Y., Park C. S. Diagnostic approach to thyroid carcinoma in Graves' disease. Yonsei Med J. 1993 Jun;34(2):191–194. doi: 10.3349/ymj.1993.34.2.191. [DOI] [PubMed] [Google Scholar]
  32. Soravia C., Sugg S. L., Berk T., Mitri A., Cheng H., Gallinger S., Cohen Z., Asa S. L., Bapat B. V. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol. 1999 Jan;154(1):127–135. doi: 10.1016/S0002-9440(10)65259-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sugg S. L., Ezzat S., Rosen I. B., Freeman J. L., Asa S. L. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab. 1998 Nov;83(11):4116–4122. doi: 10.1210/jcem.83.11.5271. [DOI] [PubMed] [Google Scholar]
  34. Suárez H. G. Genetic alterations in human epithelial thyroid tumours. Clin Endocrinol (Oxf) 1998 May;48(5):531–546. doi: 10.1046/j.1365-2265.1998.00443.x. [DOI] [PubMed] [Google Scholar]
  35. Takahashi M., Buma Y., Iwamoto T., Inaguma Y., Ikeda H., Hiai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene. 1988 Nov;3(5):571–578. [PubMed] [Google Scholar]
  36. Viglietto G., Chiappetta G., Martinez-Tello F. J., Fukunaga F. H., Tallini G., Rigopoulou D., Visconti R., Mastro A., Santoro M., Fusco A. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene. 1995 Sep 21;11(6):1207–1210. [PubMed] [Google Scholar]
  37. Walker R. P., Paloyan E. The relationship between Hashimoto's thyroiditis, thyroid neoplasia, and primary hyperparathyroidism. Otolaryngol Clin North Am. 1990 Apr;23(2):291–302. [PubMed] [Google Scholar]
  38. Wirtschafter A., Schmidt R., Rosen D., Kundu N., Santoro M., Fusco A., Multhaupt H., Atkins J. P., Rosen M. R., Keane W. M. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope. 1997 Jan;107(1):95–100. doi: 10.1097/00005537-199701000-00019. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES